{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T14:55:35Z","timestamp":1777128935770,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish State Research Agency and EDR Funds","award":["SAF-2017-88126-R"],"award-info":[{"award-number":["SAF-2017-88126-R"]}]},{"name":"Spanish State Research Agency and EDR Funds","award":["PID2019-106404RB-100"],"award-info":[{"award-number":["PID2019-106404RB-100"]}]},{"name":"Spanish State Research Agency and EDR Funds","award":["2011\u201029918"],"award-info":[{"award-number":["2011\u201029918"]}]},{"DOI":"10.13039\/501100003086","name":"Basque Government","doi-asserted-by":"crossref","award":["IT1211\/19)"],"award-info":[{"award-number":["IT1211\/19)"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s43440-021-00248-w","type":"journal-article","created":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T04:18:16Z","timestamp":1617941896000},"page":"1155-1163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["5-HT2A receptor- and M1 muscarinic acetylcholine receptor-mediated activation of G\u03b1q\/11 in postmortem dorsolateral prefrontal cortex of opiate addicts"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1792-028X","authenticated-orcid":false,"given":"Yuji","family":"Odagaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7913-6714","authenticated-orcid":false,"given":"J. Javier","family":"Meana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9941-012X","authenticated-orcid":false,"given":"Luis F.","family":"Callado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5143-2442","authenticated-orcid":false,"given":"Jes\u00fas A.","family":"Garc\u00eda-Sevilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"key":"248_CR1","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","volume":"85","author":"G Di Chiara","year":"1988","unstructured":"Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA. 1988;85:5274\u20138. https:\/\/doi.org\/10.1073\/pnas.85.14.5274.","journal-title":"Proc Natl Acad Sci USA"},{"key":"248_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/syn.890210207","volume":"21","author":"RA Wise","year":"1995","unstructured":"Wise RA, Leone P, Rivest R, Leeb K. Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration. Synapse. 1995;21:140\u20138. https:\/\/doi.org\/10.1002\/syn.890210207.","journal-title":"Synapse"},{"key":"248_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0014-2999(88)90756-x","volume":"150","author":"U Spampinato","year":"1988","unstructured":"Spampinato U, Gozlan H, Daval G, Fattaccini CM, Hamon M. Dopamine receptor subsensitivity in the substantia nigra after chronic morphine treatment in rats. Eur J Pharmacol. 1988;150:113\u201322. https:\/\/doi.org\/10.1016\/0014-2999(88)90756-x.","journal-title":"Eur J Pharmacol."},{"key":"248_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0304-3940(93)90360-w","volume":"163","author":"R Simantov","year":"1993","unstructured":"Simantov R. Chronic morphine alters dopamine transporter density in the rat brain: possible role in the mechanism of drug addiction. Neurosci Lett. 1993;163:121\u20134. https:\/\/doi.org\/10.1016\/0304-3940(93)90360-w.","journal-title":"Neurosci Lett."},{"key":"248_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.neuropharm.2011.03.022","volume":"61","author":"LG Kirby","year":"2011","unstructured":"Kirby LG, Zeeb FD, Winstanley CA. Contributions of serotonin in addiction vulnerability. Neuropharmacology. 2011;61:421\u201332. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.03.022.","journal-title":"Neuropharmacology."},{"key":"248_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bbr.2014.04.007","volume":"277","author":"CP M\u00fcller","year":"2015","unstructured":"M\u00fcller CP, Homberg JR. The role of serotonin in drug use and addiction. Behav Brain Res. 2015;277:146\u201392. https:\/\/doi.org\/10.1016\/j.bbr.2014.04.007.","journal-title":"Behav Brain Res"},{"key":"248_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s40263-018-0572-y","volume":"32","author":"KP Jensen","year":"2018","unstructured":"Jensen KP, DeVito EE, Yip S, Carroll KM, Sofuoglu M. The cholinergic system as a treatment target for opioid use disorder. CNS Drugs. 2018;32:981\u201396. https:\/\/doi.org\/10.1007\/s40263-018-0572-y.","journal-title":"CNS Drugs"},{"key":"248_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00401-013-1221-7","volume":"127","author":"JL Cadet","year":"2014","unstructured":"Cadet JL, Bisagno V, Milroy CM. Neuropathology of substance use disorders. Acta Neuropathol. 2014;127:91\u2013107. https:\/\/doi.org\/10.1007\/s00401-013-1221-7.","journal-title":"Acta Neuropathol"},{"key":"248_CR9","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1001\/archpsyc.1994.03950060058006","volume":"51","author":"PV Escriba","year":"1994","unstructured":"Escriba PV, Sastre M, Garc\u00eda-Sevilla JA. Increased density of guanine nucleotide-binding proteins in the postmortem brains of heroin addicts. Arch Gen Psychiatry. 1994;51:494\u2013501. https:\/\/doi.org\/10.1001\/archpsyc.1994.03950060058006.","journal-title":"Arch Gen Psychiatry."},{"key":"248_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF02244763","volume":"115","author":"AM Gabilondo","year":"1994","unstructured":"Gabilondo AM, Meana JJ, Barturen F, Sastre M, Garc\u00eda-Sevilla JA. \u03bc-Opioid receptor and \u221d2-adrenoceptor agonist binding sites in the postmortem brain of heroin addicts. Psychopharmacology (Berl). 1994;115:135\u201340. https:\/\/doi.org\/10.1007\/BF02244763.","journal-title":"Psychopharmacology (Berl)"},{"issue":"9 Suppl","key":"248_CR11","doi-asserted-by":"publisher","first-page":"301A","DOI":"10.1111\/j.1530-0277.1996.tb01797.x","volume":"20","author":"E Hashimoto","year":"1996","unstructured":"Hashimoto E, Fr\u00f6lich L, Ozawa H, Saito T, Shichinohe S, Takahata N, et al. Alteration of glutamyltranspeptidase binding proteins in postmortem brains of heroin addicts. Alcohol Clin Exp Res. 1996;20(9 Suppl):301A-304A.","journal-title":"Alcohol Clin Exp Res"},{"key":"248_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/00001756-199601310-00032","volume":"7","author":"M Sastre","year":"1996","unstructured":"Sastre M, Ventayol P, Garc\u00eda-Sevilla JA. Decreased density of I2-imidazoline receptors in the postmortem brain of heroin addicts. Neuroreport. 1996;7:509\u201312. https:\/\/doi.org\/10.1097\/00001756-199601310-00032.","journal-title":"Neuroreport"},{"key":"248_CR13","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1097\/00001756-199705060-00003","volume":"8","author":"JA Garc\u00eda-Sevilla","year":"1997","unstructured":"Garc\u00eda-Sevilla JA, Ventayol P, Busquets X, La Harpe R, Walzer C, Guim\u00f3n J. Marked decrease of immunolabelled 68 kDa neurofilament (NF-L) proteins in brains of opiate addicts. Neuroreport. 1997;8:1561\u20135. https:\/\/doi.org\/10.1097\/00001756-199705060-00003.","journal-title":"Neuroreport"},{"key":"248_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0304-3940(97)00227-9","volume":"226","author":"JA Garc\u00eda-Sevilla","year":"1997","unstructured":"Garc\u00eda-Sevilla JA, Ventayol P, Busquets X, La Harpe R, Walzer C, Guim\u00f3n J. Regulation of immunolabelled \u03bc-opioid receptors and protein kinase C-\u221d and \u03b6 isoforms in the frontal cortex of human opiate addicts. Neurosci Lett. 1997;226:29\u201332. https:\/\/doi.org\/10.1016\/s0304-3940(97)00227-9.","journal-title":"Neurosci Lett"},{"issue":"S3 Pt 1","key":"248_CR15","doi-asserted-by":"publisher","first-page":"84S","DOI":"10.1111\/acer.1998.22.s3_part1.84s","volume":"22","author":"S Shichinohe","year":"1998","unstructured":"Shichinohe S, Ozawa H, Saito T, Hashimoto E, Lang C, Riederer P, et al. Differential alteration of adenylyl cyclase subtypes I, II, and V\/VI in postmortem human brains of heroin addicts. Alcohol Clin Exp Res. 1998;22(S3 Pt 1):84S-87S. https:\/\/doi.org\/10.1111\/acer.1998.22.s3_part1.84s.","journal-title":"Alcohol Clin Exp Res"},{"key":"248_CR16","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/sj.mp.4000727","volume":"5","author":"JJ Meana","year":"2000","unstructured":"Meana JJ, Gonz\u00e1lez-Maeso J, Garc\u00eda-Sevilla JA, Guim\u00f3n J. \u03bc-Opioid receptor and \u03b12-adrenoceptor agonist stimulation of [35S]GTP\u03b3S binding to G-proteins in postmortem brains of opioid addicts. Mol Psychiatry. 2000;5:308\u201315. https:\/\/doi.org\/10.1038\/sj.mp.4000727.","journal-title":"Mol Psychiatry."},{"key":"248_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s007020170079","volume":"108","author":"S Shichinohe","year":"2001","unstructured":"Shichinohe S, Ozawa H, Hashimoto E, Tatschner T, Riederer P, Saito T. Changes in the cAMP-related signal transduction mechanism in postmortem human brains of heroin addicts. J Neural Transm. 2001;108:335\u201347. https:\/\/doi.org\/10.1007\/s007020170079.","journal-title":"J Neural Transm."},{"key":"248_CR18","doi-asserted-by":"publisher","unstructured":"Ferrer-Alc\u00f3n M, La Harpe R, Guim\u00f3n J, Garc\u00eda-Sevilla JA. Downregulation of neuronal cdk5\/p35 in opioid addicts and opiate-treated rats: relation to neurofilament phosphorylation. Neuropsychopharmacology. 2003;28:947\u201355. https:\/\/doi.org\/10.1038\/sj.npp.1300095.","DOI":"10.1038\/sj.npp.1300095"},{"key":"248_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.molbrainres.2003.11.009","volume":"121","author":"M Ferrer-Alc\u00f3n","year":"2004","unstructured":"Ferrer-Alc\u00f3n M, La Harpe R, Garc\u00eda-Sevilla JA. Decreased immunodensities of micro-opioid receptors, receptor kinases GRK 2\/6 and \u03b2-arrestin-2 in postmortem brains of opiate addicts. Brain Res Mol Brain Res. 2004;121:114\u201322. https:\/\/doi.org\/10.1016\/j.molbrainres.2003.11.009.","journal-title":"Brain Res Mol Brain Res"},{"key":"248_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neuroscience.2008.09.002","volume":"157","author":"MJ Garc\u00eda-Fuster","year":"2008","unstructured":"Garc\u00eda-Fuster MJ, Ramos-Miguel A, Rivero G, La Harpe R, Meana JJ, Garc\u00eda-Sevilla JA. Regulation of the extrinsic and intrinsic apoptotic pathways in the prefrontal cortex of short- and long-term human opiate abusers. Neuroscience. 2008;157:105\u201319. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.09.002.","journal-title":"Neuroscience."},{"key":"248_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.biopsych.2013.04.012","volume":"74","author":"SE Sillivan","year":"2013","unstructured":"Sillivan SE, Whittard JD, Jacobs MM, Ren Y, Mazloom AR, Caputi FF, et al. ELK1 transcription factor linked to dysregulated striatal mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers. Biol Psychiatry. 2013;74:511\u20139. https:\/\/doi.org\/10.1016\/j.biopsych.2013.04.012.","journal-title":"Biol Psychiatry."},{"key":"248_CR22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.neuint.2017.04.017","volume":"108","author":"B Keller","year":"2017","unstructured":"Keller B, La Harpe R, Garc\u00eda-Sevilla JA. Upregulation of IRAS\/nischarin (I1-imidazoline receptor), a regulatory protein of \u03bc-opioid receptor trafficking, in postmortem prefrontal cortex of long-term opiate and mixed opiate\/cocaine abusers. Neurochem Int. 2017;108:282\u20136. https:\/\/doi.org\/10.1016\/j.neuint.2017.04.017.","journal-title":"Neurochem Int."},{"key":"248_CR23","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00702-017-1749-0","volume":"124","author":"Y Odagaki","year":"2017","unstructured":"Odagaki Y, Kinoshita M, Ota T, Meana JJ, Callado LF, Garc\u00eda-Sevilla JA. Functional activation of G\u221dq\u00a0coupled to 5-HT2A\u00a0receptor and M1\u00a0muscarinic acetylcholine receptor in postmortem human cortical membranes. J Neural Transm. 2017;124:1123\u201333. https:\/\/doi.org\/10.1007\/s00702-017-1749-0.","journal-title":"J Neural Transm."},{"key":"248_CR24","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/ejhg.2012.249","volume":"21","author":"J Arias-Diaz","year":"2013","unstructured":"Arias-Diaz J, Mart\u00edn-Arribas MC, Garc\u00eda del Pozo J, Alonso C. Spanish regulatory approach for biobanking. Eur J Hum Genet. 2013;21:708\u201312. https:\/\/doi.org\/10.1038\/ejhg.2012.249.","journal-title":"Eur J Hum Genet"},{"key":"248_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s00210-004-0951-4","volume":"370","author":"AR Knight","year":"2004","unstructured":"Knight AR, Misra A, Quirk K, Benwell K, Revell D, Kennett G, et al. Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors. Naunyn-Schmiedebergs Arch Pharmacol. 2004;370:114\u201323. https:\/\/doi.org\/10.1007\/s00210-004-0951-4.","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"248_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0304-3940(94)90561-4","volume":"181","author":"H Canton","year":"1994","unstructured":"Canton H, Verri\u00e8le L, Millan MJ. Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptor-mediated phosphoinositide (PI) turnover by clozapine in the rat: a comparison to other antipsychotics. Neurosci Lett. 1994;181:65\u20138. https:\/\/doi.org\/10.1016\/0304-3940(94)90561-4.","journal-title":"Neurosci Lett"},{"key":"248_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejphar.2013.12.040","volume":"726","author":"Y Odagaki","year":"2014","unstructured":"Odagaki Y, Kinoshita M, Toyoshima R. Functional activation of G\u03b1q via serotonin2A (5-HT2A) and muscarinic acetylcholine M1 receptors assessed by guanosine-5\u2019-O-(3-[35S]thio)triphosphate ([35S]GTP\u03b3S) binding\/immunoprecipitation in rat brain membranes. Eur J Pharmacol. 2014;726:109\u201315. https:\/\/doi.org\/10.1016\/j.ejphar.2013.12.040.","journal-title":"Eur J Pharmacol."},{"key":"248_CR28","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1523\/JNEUROSCI.11-10-03218.1991","volume":"11","author":"AI Levey","year":"1991","unstructured":"Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci. 1991;11:3218\u201326. https:\/\/doi.org\/10.1523\/JNEUROSCI.11-10-03218.1991.","journal-title":"J Neurosci"},{"key":"248_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0306-4522(94)90017-5","volume":"63","author":"AI Levey","year":"1994","unstructured":"Levey AI, Edmunds SM, Heilman CJ, Desmond TJ, Frey KA. Localization of muscarinic m3 receptor protein and M3 receptor binding in rat brain. Neuroscience. 1994;63:207\u201321. https:\/\/doi.org\/10.1016\/0306-4522(94)90017-5.","journal-title":"Neuroscience."},{"key":"248_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0304-3940(84)90151-4","volume":"49","author":"T Bardon","year":"1984","unstructured":"Bardon T, Ruckebusch M. Changes in 5-HIAA and 5-HT levels in lumbar CSF following morphine administration to conscious dogs. Neurosci Lett. 1984;49:147\u201351. https:\/\/doi.org\/10.1016\/0304-3940(84)90151-4.","journal-title":"Neurosci Lett."},{"key":"248_CR31","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1046\/j.1471-4159.1994.63020517.x","volume":"63","author":"R Tao","year":"1994","unstructured":"Tao R, Auerbach SB. Increased extracellular serotonin in rat brain after systemic or intraraphe administration of morphine. J Neurochem. 1994;63:517\u201324. https:\/\/doi.org\/10.1046\/j.1471-4159.1994.63020517.x.","journal-title":"J Neurochem"},{"key":"248_CR32","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.2967\/jnumed.112.103796","volume":"53","author":"AM Adriaens","year":"2012","unstructured":"Adriaens AM, Polis IE, Vermeire ST, Waelbers T, Duchateau L, Sys SU, et al. The influence of morphine on cerebral 5-HT2A availability in dogs: a SPECT study. J Nucl Med. 2012;53:1969\u201373. https:\/\/doi.org\/10.2967\/jnumed.112.103796.","journal-title":"J Nucl Med"},{"key":"248_CR33","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.euroneuro.2014.03.004","volume":"24","author":"A Adriaens","year":"2014","unstructured":"Adriaens A, Polis I, Vermeire S, Waelbers T, Croubels S, Duchateau L, et al. The effect of prolonged exposure to morphine on canine cerebral 5-HT2A receptors measured with 123I\u2013R91150 SPECT. Eur Neuropsychopharmacol. 2014;24:1133\u20138. https:\/\/doi.org\/10.1016\/j.euroneuro.2014.03.004.","journal-title":"Eur Neuropsychopharmacol"},{"key":"248_CR34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.15412\/J.BCN.03070310","volume":"7","author":"R Mohammadi","year":"2016","unstructured":"Mohammadi R, Jahanshahi M, Jameie SB. 5-HT2A serotonin receptor density in adult male rats\u2019 hippocampus after morphine-based conditioned place preference. Basic Clin Neurosci. 2016;7:249\u201358. https:\/\/doi.org\/10.15412\/J.BCN.03070310.","journal-title":"Basic Clin Neurosci"},{"key":"248_CR35","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fphar.2016.00514","volume":"7","author":"G Pang","year":"2016","unstructured":"Pang G, Wu X, Tao X, Mao R, Liu X, Zhang Y-M, et al. Blockade of serotonin 5-HT2A\u00a0receptors suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-treated mice. Front Pharmacol. 2016;7:514. https:\/\/doi.org\/10.3389\/fphar.2016.00514.","journal-title":"Front Pharmacol."},{"key":"248_CR36","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/0028-3908(88)90025-1","volume":"27","author":"A Gulati","year":"1988","unstructured":"Gulati A, Bhargava HN. Cerebral cortical 5-HT1 and 5-HT2 receptors of morphine tolerant-dependent rats. Neuropharmacology. 1988;27:1231\u20137. https:\/\/doi.org\/10.1016\/0028-3908(88)90025-1.","journal-title":"Neuropharmacology."},{"key":"248_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0014-2999(89)90578-5","volume":"167","author":"A Gulati","year":"1989","unstructured":"Gulati A, Bhargava HN. Brain and spinal cord 5-HT2 receptors of morphine-tolerant-dependent and -abstinent rats. Eur J Pharmacol. 1989;167:185\u201392. https:\/\/doi.org\/10.1016\/0014-2999(89)90578-5.","journal-title":"Eur J Pharmacol"},{"key":"248_CR38","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1124\/jpet.119.258004","volume":"371","author":"KE Dunn","year":"2019","unstructured":"Dunn KE, Huhn AS, Bergeria CL, Gipson CD, Weerts EM. Non-opioid neurotransmitter systems that contribute to the opioid withdrawal syndrome: a review of preclinical and human evidence. J Pharmacol Exp Ther. 2019;371:422\u201352. https:\/\/doi.org\/10.1124\/jpet.119.258004.","journal-title":"J Pharmacol Exp Ther."},{"key":"248_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejphar.2017.11.039","volume":"819","author":"X Liu","year":"2018","unstructured":"Liu X, Tian L, Cui R, Ruan H, Li X. Muscarinic receptors in the nucleus accumbens shell play different roles in context-induced or morphine-challenged expression of behavioral sensitization in rats. Eur J Pharmacol. 2018;819:51\u20137. https:\/\/doi.org\/10.1016\/j.ejphar.2017.11.039.","journal-title":"Eur J Pharmacol"},{"key":"248_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/syn.20067","volume":"54","author":"J-H Yoo","year":"2004","unstructured":"Yoo J-H, Lee S-Y, Loh HH, Ho IK, Jang C-G. Altered emotional behaviors and the expression of 5-HT1A and M1 muscarinic receptors in \u03bc-opioid receptor knockout mice. Synapse. 2004;54:72\u201382. https:\/\/doi.org\/10.1002\/syn.20067.","journal-title":"Synapse"},{"key":"248_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.molbrainres.2004.03.011","volume":"126","author":"L-T Tien","year":"2004","unstructured":"Tien L-T, Fan L-W, Sogawa C, Ma T, Loh HH, Ho I-K. Changes in acetylcholinesterase activity and muscarinic receptor bindings in \u03bc-opioid receptor knockout mice. Brain Res Mol Brain Res. 2004;126:38\u201344. https:\/\/doi.org\/10.1016\/j.molbrainres.2004.03.011.","journal-title":"Brain Res Mol Brain Res."},{"key":"248_CR42","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1016\/j.neubiorev.2012.06.006","volume":"36","author":"A Baldacchino","year":"2012","unstructured":"Baldacchino A, Balfour DJK, Passetti F, Humphris G, Matthews K. Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis. Neurosci Biobehav Rev. 2012;36:2056\u201368. https:\/\/doi.org\/10.1016\/j.neubiorev.2012.06.006.","journal-title":"Neurosci Biobehav Rev."},{"key":"248_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.drugalcdep.2010.07.013","volume":"113","author":"M Torrens","year":"2011","unstructured":"Torrens M, Gilchrist G, Domingo-Salvany A, psyCoBarcelona Group. Psychiatric comorbidity in illicit drug users: substance-induced versus independent disorders. Drug Alcohol Depend. 2011;113:147\u201356. https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.07.013.","journal-title":"Drug Alcohol Depend"},{"key":"248_CR44","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00406-019-01088-9","volume":"270","author":"Y Odagaki","year":"2020","unstructured":"Odagaki Y, Kinoshita M, Meana JJ, Callado LF, Garc\u00eda-Sevilla JA. Functional coupling of M1\u00a0muscarinic acetylcholine receptor to G\u221dq\/11\u00a0in dorsolateral prefrontal cortex from patients with psychiatric disorders: a postmortem study. Eur Arch Psychiatry Clin Neurosci. 2020;270:869\u201380. https:\/\/doi.org\/10.1007\/s00406-019-01088-9.","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"248_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15622975.2020.1839967","volume":"2020","author":"Y Odagaki","year":"2020","unstructured":"Odagaki Y, Kinoshita M, Meana JJ, Callado LF, Garc\u00eda-Sevilla JA. 5-HT2A\u00a0receptor-mediated G\u221dq\/11\u00a0activation in psychiatric disorders: A postmortem study. World J Biol Psychiatry. 2020;2020:1\u201311. https:\/\/doi.org\/10.1080\/15622975.2020.1839967.","journal-title":"World J Biol Psychiatry"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-021-00248-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-021-00248-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-021-00248-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T15:36:52Z","timestamp":1630683412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-021-00248-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["248"],"URL":"https:\/\/doi.org\/10.1007\/s43440-021-00248-w","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,9]]},"assertion":[{"value":"23 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Collection procedures of postmortem human brains were performed in accordance with the protocol for postmortem human brain research of the Basque Institute of Legal Medicine. The study was approved by the Research and Ethics Boards of both the University of the Basque Country, Spain and the Faculty of Medicine, Saitama Medical University, Japan.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}